672-87-7 Usage
Description
ALPHA-METHYL-L-P-TYROSINE, also known as α-Methyl-L-tyrosine, is an organic compound that serves as a competitive inhibitor of the enzyme tyrosine hydroxylase. It is structurally similar to the amino acid L-tyrosine, with a methyl group added to the alpha carbon. ALPHA-METHYL-L-P-TYROSINE plays a significant role in various applications across different industries due to its ability to modulate the activity of tyrosine hydroxylase.
Used in Pharmaceutical Industry:
ALPHA-METHYL-L-P-TYROSINE is used as an antihypertensive agent for the treatment of pheochromocytoma, a rare tumor of the adrenal gland that can lead to high blood pressure. It functions by inhibiting the enzyme tyrosine hydroxylase, which is crucial for the synthesis of catecholamines, including dopamine, norepinephrine, and epinephrine. By reducing the production of these hormones, ALPHA-METHYL-L-P-TYROSINE helps control blood pressure in patients with pheochromocytoma.
Used in Neuroscientific Research:
ALPHA-METHYL-L-P-TYROSINE is used as a research tool to investigate the role of dopamine and iron-mediated oxidative stress in cell death induced by Fe2+ or methamphetamine (METH). By inhibiting tyrosine hydroxylase, this compound can help determine the dependence of cell death on cytosolic dopamine levels, providing valuable insights into the underlying mechanisms of neurodegeneration and potential therapeutic targets for related conditions.
Originator
Demser,MSD,US,1979
Manufacturing Process
50 g of α-methyl-N-dichloroacetyl-p-nitrophenylalanine was dissolved in 500
ml methanol, 300 mg of platinum oxide were added and the mixture reduced
at 41 pounds of pressure; within an hour 14.5 pounds were used up (theory
12.4 pounds). After filtration of the catalyst, the red clear filtrate was
concentrated in vacuo and the residual syrup flushed several times with ether.
The crystalline residue thus obtained, after air drying, weighed 45.3 g
(99.5%), MP unsharp at about 104°C to 108°C with decomposition. After two
precipitations with ether from an alcoholic solution, the somewhat hygroscopic
amine was dried over sulfuric acid for analysis.10 g of the amine prepared above was dissolved in 5 ml of 50% sulfuric acid
at room temperature; the viscous solution was then cooled in ice and a
solution of sodium nitrite (2.4 g) in 10 ml water gradually added with
agitation. A flocculent precipitate formed. After all the nitrite had been added,
the mixture was aged in ice for an hour, after which it was allowed to warm
up to room temperature. Nitrogen came off and the precipitate changed to a
sticky oil. After heating on the steam bath until evolution of nitrogen ceased,
the oil was extracted with ethyl acetate. After removal of the solvent in vacuo,
9.4 g of colored solid residue was obtained, which was refluxed with 150 ml
hydrochloric acid (1:1) for 17 hours. The resulting dark solution; after Norite
treatment and extraction with ethyl acetate, was concentrated in vacuo to
dryness and the tan colored residue (7.4 g) sweetened with ethanol.
Dissolution of the residue in minimum amount of ethanol and neutralization
with diethylamine of the clarified solution, precipitated the α-methyl tyrosine,
which was filtered, washed with ethanol (until free of chlorides) and ether. The
crude amino acid melted at 309°C with decomposition. For further purification,
it was dissolved in 250 ml of a saturated sulfur dioxide-water solution, and the
solution, after Noriting, concentrated to about 80 ml, the tan colored solid
filtered washed with ethanol and ether. Obtained 1.5 g of α-methyl tyrosine,
MP 320°C dec.
Therapeutic Function
Tyrosine hydroxylase inhibitor
Biochem/physiol Actions
α-Methyl-L-tyrosine (L-AMPT) acts as a competitive inhibitor of tyrosine hydroxylase and inhibits the conversion of tyrosine to L-DOPA and eventually lowers dopamine synthesis in cytosol. AMPT at low concentrations can be used as a potent therapeutic for refractory dystonia or dyskinesia. It also helps in decreasing catecholamine concentration in pheochromocytoma patients.
Check Digit Verification of cas no
The CAS Registry Mumber 672-87-7 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,7 and 2 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 672-87:
(5*6)+(4*7)+(3*2)+(2*8)+(1*7)=87
87 % 10 = 7
So 672-87-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H13NO3/c1-10(11,9(13)14)6-7-2-4-8(12)5-3-7/h2-5,12H,6,11H2,1H3,(H,13,14)/t10-/m0/s1
672-87-7Relevant articles and documents
METHOD FOR PRODUCING AMINO ACID AND AMINO ACID SYNTHESIS KIT
-
Paragraph 0124-0126, (2017/04/03)
PROBLEM TO BE SOLVED: To provide a method for producing an amino acid and an amino acid synthesis kit, which enable synthesis of a desired amino acid in high stereoselectivity efficiently and in a very short time, irrespective whether a radioactive isotope is contained or not. SOLUTION: A method for producing an amino acid and an amino acid synthesis kit are disclosed. The method for producing an amino acid of the present invention comprises a step of alkylating a substrate compound with an alkylating agent in the presence of an optically active phase transfer catalyst as well as a medium and an inorganic base. An amount of use of the optically active phase transfer catalyst is 1 equivalent or more and 1000 equivalents or less relative to the alkylating agent. According to the present invention, a desired amino acid and a derivative thereof can be produced in high stereoselectivity efficiently and in a very short time. Therefore, the present production method is useful, for example, for research and development, and production of a radioactively labelled amino acid and a derivative thereof, which can be used as a tracer for neurodegenerative diseases such as Parkinson disease and Alzheimer disease, heart diseases, and cancerous diseases. SELECTED DRAWING: None COPYRIGHT: (C)2016,JPOandINPIT
STEREOSELECTIVE SYNTHESIS OF METYROSINE
-
Page/Page column 21, (2011/05/08)
Provided herein are compositions including diastereomers in substantially diastereomerically pure form and enantiomers in substantially enantiomerically pure form, and processes for preparing them and converting them to metyrosine.
Kinetic Resolution of Unnatural and Rarely Occuring Amino Acids: Enantioselective Hydrolysis of N-Acyl Amino Acids Catalyzed by Acylase I
Chenault, H. Keith,Dahmer, Juergen,Whitesides, George M.
, p. 6354 - 6364 (2007/10/02)
Acylase I (aminoacylase; N-acylamino-acid amidohydrolase, EC 3.5.1.14, from porcine kidney and the fungus Aspergillus) is broadly applicable enzymatic catalyst for the kinetic resolution of unnatural and rarely occuring α-amino acids.Its enantioselectivity for the hydrolysis of N-acyl L-α-amino acids is nearly absolute, yet it accepts substrates having a wide range of structure and functionality.This paper reports the initial rates of enzyme-catalyzed hydrolysis of over 50 N-acyl amino acids and analogues, the stabilities of the enzymes in aqueous and aqueous/organic solutions, and the effects of different acyl groups and metal ions on the rates of enzymatic hydrolysis.Eleven α-amino and α-methyl α-amino acids were resolved on a 2-29-g scale.Crude L- and D-amino acid products had generally >90percent ee.The utility of resolved amino acids as chiral synthons was illustrated by the preparation of (R)- and (S)-1-butene oxide and the diastereoselective (cis:trans, 7-8:1) iodolactonization of three 2-amino-4-alkenoic acid derivatives.